141 related articles for article (PubMed ID: 18596910)
1. Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication.
Xiang J; McLinden JH; Chang Q; Jordan EL; Stapleton JT
PLoS One; 2008 Jul; 3(7):e2580. PubMed ID: 18596910
[TBL] [Abstract][Full Text] [Related]
2. The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression.
George SL; Varmaz D; Tavis JE; Chowdhury A
PLoS One; 2012; 7(1):e30653. PubMed ID: 22292009
[TBL] [Abstract][Full Text] [Related]
3. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells.
Xiang J; McLinden JH; Chang Q; Kaufman TM; Stapleton JT
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15570-5. PubMed ID: 17030806
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication.
Xiang J; McLinden JH; Kaufman TM; Mohr EL; Bhattarai N; Chang Q; Stapleton JT
Virology; 2012 Aug; 430(1):53-62. PubMed ID: 22608061
[TBL] [Abstract][Full Text] [Related]
5. Expression of GB virus C NS5A protein from genotypes 1, 2, 3 and 5 and a 30 aa NS5A fragment inhibit human immunodeficiency virus type 1 replication in a CD4+ T-lymphocyte cell line.
Chang Q; McLinden JH; Stapleton JT; Sathar MA; Xiang J
J Gen Virol; 2007 Dec; 88(Pt 12):3341-3346. PubMed ID: 18024904
[TBL] [Abstract][Full Text] [Related]
6. Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.
Xiang J; McLinden JH; Rydze RA; Chang Q; Kaufman TM; Klinzman D; Stapleton JT
J Immunol; 2009 Dec; 183(12):7860-9. PubMed ID: 19923460
[TBL] [Abstract][Full Text] [Related]
7. Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells.
McLinden JH; Stapleton JT; Klinzman D; Murthy KK; Chang Q; Kaufman TM; Bhattarai N; Xiang J
J Gen Virol; 2013 Apr; 94(Pt 4):774-782. PubMed ID: 23288422
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors.
Jung S; Knauer O; Donhauser N; Eichenmüller M; Helm M; Fleckenstein B; Reil H
AIDS; 2005 Aug; 19(12):1267-72. PubMed ID: 16052081
[TBL] [Abstract][Full Text] [Related]
10. Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication.
McLinden JH; Stapleton JT; Chang Q; Xiang J
J Infect Dis; 2008 Sep; 198(6):860-3. PubMed ID: 18721058
[TBL] [Abstract][Full Text] [Related]
11. GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling.
Bhattarai N; McLinden JH; Xiang J; Landay AL; Chivero ET; Stapleton JT
J Immunol; 2013 Jun; 190(12):6351-9. PubMed ID: 23686495
[TBL] [Abstract][Full Text] [Related]
12. Structure-function study and anti-HIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II.
Luo Z; Fan X; Zhou N; Hiraoka M; Luo J; Kaji H; Huang Z
Biochemistry; 2000 Nov; 39(44):13545-50. PubMed ID: 11063591
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds.
Gómara MJ; Galatola R; Gutiérrez A; Gimeno MC; Gatell JM; Sánchez-Merino V; Yuste E; Haro I
Curr Med Chem; 2014; 21(2):238-50. PubMed ID: 24083612
[TBL] [Abstract][Full Text] [Related]
14. GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation.
Xiang J; Martinez-Smith C; Gale M; Chang Q; Labrecque DR; Schmidt WN; Stapleton JT
J Interferon Cytokine Res; 2005 May; 25(5):261-70. PubMed ID: 15871663
[TBL] [Abstract][Full Text] [Related]
15. GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways.
Bhattarai N; McLinden JH; Xiang J; Kaufman TM; Stapleton JT
J Immunol; 2012 Sep; 189(5):2211-6. PubMed ID: 22844114
[TBL] [Abstract][Full Text] [Related]
16. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.
Stapleton JT; Chaloner K; Zhang J; Klinzman D; Souza IE; Xiang J; Landay A; Fahey J; Pollard R; Mitsuyasu R
AIDS; 2009 Mar; 23(5):605-10. PubMed ID: 19194270
[TBL] [Abstract][Full Text] [Related]
17. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
[TBL] [Abstract][Full Text] [Related]
18. Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection.
Fernández L; Chan WC; Egido M; Gómara MJ; Haro I
J Pept Sci; 2012 May; 18(5):326-35. PubMed ID: 22438139
[TBL] [Abstract][Full Text] [Related]
19. GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals.
Polgreen PM; Xiang J; Chang Q; Stapleton JT
Microbes Infect; 2003 Nov; 5(13):1255-61. PubMed ID: 14623022
[TBL] [Abstract][Full Text] [Related]
20. A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor.
Fenard D; Lambeau G; Maurin T; Lefebvre JC; Doglio A
Mol Pharmacol; 2001 Aug; 60(2):341-7. PubMed ID: 11455021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
